Skip to main content

Caption Management, LLC

Position in XENE — Xenon Pharmaceuticals Inc.

CIK 1706766 OKLAHOMA CITY, OK

Position in XENE

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2021
11 quarters on record

Common Shares in XENE Over Time

Shares Held

Position Value (USD)

Derivatives in XENE

reported options exposure · as of Mar 31, 2026
CallValue
$57,114,930
CallShares
982,200
PutValue
$20,683,955
PutShares
355,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Caption Management, LLC holds $196,103,961 across 70 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in XENE

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $20,683,955 355,700
2026-03-31 $57,114,930 982,200
2025-12-31 $12,997,800 290,000
2025-12-31 $12,997,800 290,000
2025-09-30 $4,015,000 100,000
2025-09-30 $2,409,000 60,000
2025-06-30 $7,252,210 231,700
2025-06-30 $3,159,422 100,940
2025-06-30 $5,202,060 166,200
2025-03-31 $8,612,285 256,700
2024-03-31 $10,689,315 248,300
2023-12-31 $13,873,272 301,200
2023-12-31 $8,783,642 190,700
2023-09-30 $324,520 9,500
2023-09-30 $6,387,920 187,000
2023-09-30 $2,647,400 77,500
2023-03-31 $1,789,500 50,000
2022-12-31 $8,008,233 203,100
2021-09-30 $10,760,176 704,200
2021-09-30 $6,451,216 422,200